Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Trial in progress: A phase 2, multicenter, open-label study of DKN-01 in combination with tislelizumab and chemotherapy as 1L therapy in patients with unresectable, locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ; DisTinGuish).
- Authors
- Lee, Keun-Wook; Moehler, Markus H.; Cunningham, David; Wainberg, Zev A.; Uronis, Hope Elizabeth; Oh, Do-Youn; Kim, In-Ho; Shim, Byoung Yong; Sym, Sun Jin; Altura, Rachel A.; Stilian, Melissa C.; Parker, Elizabeth C.; Klempner, Samuel J.
- Issue Date
- Feb-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, pp TPS484 - TPS484
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Start Page
- TPS484
- End Page
- TPS484
- ISSN
- 0732-183X
1527-7755
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Sym, Sun Jin
- College of Medicine (Department of Medicine)